Daybreak Today Thursday Morning Brief
Lubbock hospitals see rise in COVID patients, Astrazeneca to seek vaccine approval, Biden to impose new COVID rules
On Daybreak Today,
Lubbock hospitals are dealing with an increase in COVID-19 patients.
- Both University Medical Center and Covenant Health are treating dozens of patients.
- Doctors say most of them are unvaccinated.
- KCBD NewsChannel 11′s Kase Wilbanks has more: Frustration grows at Lubbock hospitals as unvaccinated COVID-19 patients increase
Lubbock County reported 121 new cases of COVID.
- There are now 953 active cases.
- Another 120 patients are hospitalized in Lubbock’s 22-county trauma region.
Astrazeneca says it plans to seek U.S. approval for its COVID vaccine.
- The paperwork could be filed before the year is up.
- Pfizer, Moderna and Johnson & Johnson are the only companies that have vaccines approved for emergency use in the U.S.
- Read the details here: AstraZeneca to seek US approval of COVID vaccine in 2nd half of year
The FBI released its final report on a mass shooting that left eight people dead at a FedEx facility in Indianapolis.
- Investigators say the gunman planned the April shooting for months.
- There is no evidence the shootings were racially motivated.
- Get those details here: Indianapolis FedEx Shooter Who Killed 4 Sikhs Was Not Racially Motivated, Police Say
President Joe Biden is expected to announce new COVID guidelines for federal employees.
- They must either get vaccinated or submit to regular testing, masking and other conditions.
- Those who choose not to get vaccinated will not be fired.
- Read more here: White House considering vaccine mandate for federal workers
For more news, local and national, stick with KCBD on its free app and website; just look in the News section.
As always, be sure to join Sharon Maines, Steve Divine and Michael Cantu along with the rest of the Daybreak Today crew for your top headlines. Download the free KCBD NewsChannel 11 app, like us on Facebook and follow us on Twitter.
Copyright 2021 KCBD. All rights reserved.